- Home
- TDUP vs INVA Comparison
TDUP vs INVA Comparison
Compare TDUP & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDUP
- INVA
- Stock Information
- Founded
- TDUP 2009
- INVA 1996
- Country
- TDUP United States
- INVA United States
- Employees
- TDUP N/A
- INVA N/A
- Industry
- TDUP Catalog/Specialty Distribution
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- TDUP Consumer Discretionary
- INVA Health Care
- Exchange
- TDUP Nasdaq
- INVA Nasdaq
- Market Cap
- TDUP 1.3B
- INVA 1.1B
- IPO Year
- TDUP 2021
- INVA 2004
- Fundamental
- Price
- TDUP $7.47
- INVA $21.89
- Analyst Decision
- TDUP Buy
- INVA Buy
- Analyst Count
- TDUP 3
- INVA 5
- Target Price
- TDUP $12.50
- INVA $36.60
- AVG Volume (30 Days)
- TDUP 2.0M
- INVA 914.0K
- Earning Date
- TDUP 11-03-2025
- INVA 11-05-2025
- Dividend Yield
- TDUP N/A
- INVA N/A
- EPS Growth
- TDUP N/A
- INVA 53.96
- EPS
- TDUP N/A
- INVA 1.52
- Revenue
- TDUP $298,376,000.00
- INVA $388,521,000.00
- Revenue This Year
- TDUP $18.15
- INVA $7.98
- Revenue Next Year
- TDUP $9.93
- INVA $11.60
- P/E Ratio
- TDUP N/A
- INVA $14.34
- Revenue Growth
- TDUP 41.65
- INVA 10.14
- 52 Week Low
- TDUP $0.93
- INVA $16.52
- 52 Week High
- TDUP $12.28
- INVA $22.76
- Technical
- Relative Strength Index (RSI)
- TDUP 32.21
- INVA 74.96
- Support Level
- TDUP $7.54
- INVA $21.81
- Resistance Level
- TDUP $8.46
- INVA $22.51
- Average True Range (ATR)
- TDUP 0.57
- INVA 0.73
- MACD
- TDUP -0.06
- INVA 0.33
- Stochastic Oscillator
- TDUP 9.48
- INVA 83.38
About TDUP ThredUp Inc.
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.